Aller au contenu principal
2025 article

Pediatric inflammatory bowel disease patients from vulnerable areas have delayed remission and more hospitalizations

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

OBJECTIVES: Pediatric inflammatory bowel disease (IBD) has a rising incidence. While the underlying etiology is not fully understood, genetics and environmental factors are known to play a role. Social determinants of health (SDoH) also play a role in worsening morbidity and mortality for chronic diseases. This study evaluated the association between SDoH and pediatric IBD, hypothesizing that individuals residing in more socially vulnerable areas will have worse outcomes during the first year of diagnosis. METHODS: This retrospective cohort study included 222 patients diagnosed with IBD at Children's of Alabama from 2018 to 2022. The social vulnerability index (SVI) was used to quantify neighborhood-level socioeconomic vulnerability. Primary outcomes were hospitalization at diagnosis, hospitalization during the first year, disease activity at 6 months, and persistent disease activity at 1 year. RESULTS: Patients from neighborhoods in the most socioeconomically vulnerable quartile (top 25% of SVI) were more likely to be hospitalized at diagnosis (adjusted odds ratio [aOR] 2.51, p = 0.028), more likely to be hospitalized during the first year (aOR 3.44, p = 0.031), and more likely to have active disease at 6 months (unadjusted OR 2.47, p = 0.016) compared to those from neighborhoods in the least vulnerable quartile. However, there were no significant differences by neighborhood socioeconomic vulnerability in active disease at 1 year. CONCLUSION: Social vulnerability contributes to increased risk of hospitalization and delays in achieving remission during the first year after new diagnosis of IBD. This finding highlights the importance of SDoH screening to identify at-risk patients at the time of diagnosis to guide targeted interventions and prevent worse disease outcomes.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Pediatric inflammatory bowel disease patients from vulnerable areas have delayed remission and more hospitalizations
Date Crossref
18/11/2025
Éditeur
Wiley
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • University of Alabama at Birmingham Department of Pediatrics pays non établi dans la notice
    Université ou école supérieure
  • Heersink School of Medicine Department of Pediatrics pays non établi dans la notice
    Université ou école supérieure

Department of Pediatrics — University of Alabama at Birmingham et Department of Pediatrics — Heersink School of Medicine.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Inflammatory Bowel DiseaseAutoimmune and Inflammatory Disorders ResearchCeliac Disease Research and Management

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.